Ginossar Ventures

The firm seeks to invest in early-stage companies focused on b2b enterprise software, digital health, proptech, and fintech sectors.

Venture Capital Active United States
Last updated 2026-06-18
Portfolio
2
in our dataset
Rounds participated
2
Rounds led
1
Rounds' value
$9.1M
total disclosed, rounds participated
Stages

About

The firm seeks to invest in early-stage companies focused on b2b enterprise software, digital health, proptech, and fintech sectors.

Portfolio · 2

Investment activity

Portfolio by sector

Media & Entertainment Technologies1
Health Tech & Life Sciences1

Q&A

What is Ginossar Ventures' investment focus?
Ginossar Ventures seeks to invest in early-stage companies focused on B2B enterprise software, digital health, proptech, and fintech sectors.
What is Ginossar Ventures' typical investment range?
Ginossar Ventures typically invests between $1.1 million and $8 million.
Which sectors has Ginossar Ventures invested in recently?
Ginossar Ventures has recently invested in companies within the Media & Entertainment Technologies and Health Tech & Life Sciences sectors.
Can you name some of Ginossar Ventures' portfolio companies?
Ginossar Ventures' portfolio includes Yonalink, which provides data management solutions for clinical trials, and dig, focused on social video intelligence.
What was Ginossar Ventures' most recent investment activity?
Ginossar Ventures made investments in January 2022 and July 2022, adding new portfolio companies during those months.
What stages of companies does Ginossar Ventures typically invest in?
Ginossar Ventures primarily invests in Pre-Seed and Seed-stage companies.
Has Ginossar Ventures made any investments in the Health Tech & Life Sciences sector?
Yes, Ginossar Ventures has invested in the Health Tech & Life Sciences sector, with Yonalink being a notable portfolio company in this area.
What is the business model focus for Ginossar Ventures' portfolio company Yonalink?
Yonalink, a Ginossar Ventures portfolio company, operates with a B2B business model, providing data management solutions for clinical trials.